Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Leonardo Molino"'
Autor:
Vincenzo Monda, Gelsy A. Lupoli, Giovanni Messina, Rosario Peluso, Annalisa Panico, Ines Villano, Monica Salerno, Francesco Sessa, Francesca Marciello, Fiorenzo Moscatelli, Anna Valenzano, Leonardo Molino, Roberta Lupoli, Francesco Fonderico, Anna Tortora, Agata Pisano, Maria Ruberto, Marsala Gabriella, Gina Cavaliere, Giovanna Trinchese, Maria P. Mollica, Luigi Cipolloni, Giuseppe Cibelli, Marcellino Monda, Giovanni Lupoli, Antonietta Messina
Publikováno v:
Frontiers in Pharmacology, Vol 8 (2017)
The endocrine therapy is the new frontiers of many breast cancers hormone sensitive. Hormone therapy for treating women with hormone receptor-positive cancer suppresses breast cancer growth either by reducing estrogen synthesis or by interfering with
Externí odkaz:
https://doaj.org/article/34675d336e314b47bd5b0331373a7b1c
Autor:
S. Di Cosimo, Carla Ripamonti, M.A. Pessi, Marina Chiara Garassino, E.R. Haspinger, Nicoletta Zilembo, Leonardo Molino
Publikováno v:
Critical Reviews in Oncology/Hematology. 90:165-179
Purpose of research Revision of the literature on targeted therapy-induced diarrhea (TT-ID). Principal results TT-ID is frequent; the mechanisms are mainly secretive, followed by ischemic or autoimmune ones. The duration of TT-ID is protracted over t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f292098e856e90a1e1936c6023c72d65
https://doi.org/10.1016/j.critrevonc.2013.11.008
https://doi.org/10.1016/j.critrevonc.2013.11.008
Autor:
F. de Braud, Danila Serpico, Giuseppe Fanetti, Valter Torri, Leonardo Molino, S. Di Cosimo, Luca Porcu
Publikováno v:
Cancer Research. 73:P4-12
Background: Clinical trials for HER2-positive metastatic BC excluded pts with prior AdjT and/or relapsing within 1 year (yr) from the end of AdjT. With this gap in mind, we aimed to address the presentation, the therapeutic options, and the clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20666481aebd05e200a425bbef1c1c45
https://doi.org/10.1158/0008-5472.sabcs13-p4-12-22
https://doi.org/10.1158/0008-5472.sabcs13-p4-12-22
Autor:
F. de Braud, Leonardo Molino, Giuseppe Fanetti, Valter Torri, S. Di Cosimo, Luca Porcu, D. Serpico
Publikováno v:
Clinical oncology (Royal College of Radiologists (Great Britain)). 26(3)
the timing from adjuvant therapy and TTP, with a risk of progression to first-line reduced by 4% for each additional relapse-free month (hazard ratio 0.96,95% confidence interval 0.93e0.99, P ¼ 0.009). We kindly ask Lang et al. to comment on these d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c12575d93b0afeb0416d5574adca49b
https://pubmed.ncbi.nlm.nih.gov/24051172
https://pubmed.ncbi.nlm.nih.gov/24051172
Publikováno v:
Cancer treatment reviews. 40(5)
microRNAs (herein after miRNAs) represent a recently uncovered class of small and endogenous non-coding RNAs. miRNAs play a well conserved and crucial role in normal biological processes, such as cell differentiation, proliferation and apoptosis thro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8f09f5dd411379f6807df181815a66b
https://pubmed.ncbi.nlm.nih.gov/24286642
https://pubmed.ncbi.nlm.nih.gov/24286642
Autor:
Leonardo Pace, Alfredo Marinelli, Andrea Soricelli, Giovanni Storto, Marco Salvatore, Leonardo Molino, Gaetano Paone, Michele Klain, Raffaele Liuzzi
Publikováno v:
ResearcherID
Bone (New York, NY) 39 (2006): 35–41.
info:cnr-pdr/source/autori:Storto G, Klain M, Paone G, Liuzzi R, Molino L, Marinelli A, Soricelli A, Pace L, Salvatore M./titolo:Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastases/doi:/rivista:Bone (New York, NY)/anno:2006/pagina_da:35/pagina_a:41/intervallo_pagine:35–41/volume:39
Bone (New York, NY) 39 (2006): 35–41.
info:cnr-pdr/source/autori:Storto G, Klain M, Paone G, Liuzzi R, Molino L, Marinelli A, Soricelli A, Pace L, Salvatore M./titolo:Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastases/doi:/rivista:Bone (New York, NY)/anno:2006/pagina_da:35/pagina_a:41/intervallo_pagine:35–41/volume:39
Purpose: We evaluated the pain response and daily discomfort in patients with painful bone metastases treated by merging Sr-89-chloride and zoledronic acid. The results were compared with those of patients who received 89Sr-chloride or zoledronic aci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b21c8a95d96dc1a4929e0adcca2bc3a
http://hdl.handle.net/11386/3094219
http://hdl.handle.net/11386/3094219
Autor:
Valter Torri, Danila Serpico, Serena Di Cosimo, Leonardo Molino, Filippo de Braud, Luca Porcu, Anna Tessari
Publikováno v:
Journal of Clinical Oncology. 32:e11591-e11591
e11591 Background: Few reports in the literature give detailed figures on metastatic patterns in HER2+ MBC. This study reports a detailed analysis of MBC patients (pts) presentation, the developmen...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9fd85738d12b3b73fe231cb5239df9e
https://doi.org/10.1200/jco.2014.32.15_suppl.e11591
https://doi.org/10.1200/jco.2014.32.15_suppl.e11591
Autor:
Filippo de Braud, Leonardo Molino, Danila Serpico, Serena Di Cosimo, Valter Torri, Anna Tessari, Luca Porcu
Publikováno v:
Journal of Clinical Oncology. 32:e11565-e11565
e11565 Background: Trastuzumab has dramatically improved the prognosis of patients with HER2+ BC. This study reports the practice patterns across different treatment lines and the major clinical outcome of MBC patients receiving T. Methods: We analyz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7cc71adfe334933f1ae9f09bdadcabcf
https://doi.org/10.1200/jco.2014.32.15_suppl.e11565
https://doi.org/10.1200/jco.2014.32.15_suppl.e11565